rawfin.tv
ResMed Stock Rises Following RBC Capital Outperform Rating and Price Target Increase
MarketsstocksAI Generated

ResMed Stock Rises Following RBC Capital Outperform Rating and Price Target Increase

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

ResMed (NYSE: RMD) shares are trading higher after RBC Capital Markets upgraded the stock to Outperform. The firm also raised its price target, signaling increased confidence in the company's future performance.

ResMedRBC CapitalAnalyst RatingStock UpgradeHealthcare

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks